WX-Wuxi Pharmatech Stock Research, Ratings, and Analysis

Wuxi Pharmatech (wx) Stock Research

Last Updated by WikiWealth | Update This Page Now

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Long Term Rating Stock Ratings Help

BUY

SWOT Statistics wx SWOT Analysis

Strengths + Opportunities = 2

Threats + Weaknesses = 0

Add your knowledge to the Wuxi Pharmatech SWOT analysis.

Generic Strategy wx Generic Strategy

Narrow Scope

Broad Scope

None

Uniqueness

Low Cost

Generic strategies categorize companies by the scope and the strength of their business. Wuxi Pharmatech does not have a definable strategy, therefore, it risks losing out to firms that concentrate on one particular competitive advantage. (read more).

Company Description: Wuxi PharmaTech (Cayman), Inc., founded in 2000, is headquartered in Shanghai. It provides laboratory and manufacturing services in the medical device research and development process to pharmaceutical, bioTechnology, and medical device companies in the Peoples Republic of China and the United States. Update

Market Research Update

Health Care Industry Research & Analysis: The health care industry depends on the care of health-related services by professionals for the benefit of patients. Medical device markers, insurance companies, pharmaceutical drug developers and government institutions are major participants in the treatment of sick, injured and disabled patients. Health Care Trading Strategy: Health Care stocks tend to be less sensitive to economic changes. Look for undervalued health care investments at any point in the business cycle when stock prices are low. However, biotech, employment staffing and insurance companies may all decrease during recessions for different reasons. Government intervention is another important factor in health care investments, since government spending in health care is a very large portion of overall health care spending. When governments change spending plans, different sub-sectors in the industry are significantly affected. Upward sloping stock charts and financial news may indicate a selling opportunity while the opposite means that stocks are becoming undervalued.

Industry Sub Sector: . The market is quickly expanding. This lowers the threat of direct competition and increases Wuxi Pharmatech's profits.

Market Challenges: Opportunities: Solutions:

Strategy Analysis Update

Wuxi Pharmatech's business strategy is to keep things simple. Clearly-defined strategies lower business risks by staying within their areas of expertise.

Strategy: Competitive Advantages:

Financial Analysis Update

Current Revenue Sources: Future Revenue Sources: